106 related articles for article (PubMed ID: 2292053)
1. The cytolysis of human neuroblastoma cells by a natural IgM 'antibody'-complement system in pregnancy serum.
Bolande RP; Mayer DC
Cancer Invest; 1990; 8(6):603-11. PubMed ID: 2292053
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous regression of neuroblastoma: an experimental approach.
Bolande RP
Pediatr Pathol; 1990; 10(1-2):195-206. PubMed ID: 2315228
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxicity of human serum. A natural IgM 'antibody' sensitizes transformed murine cells to the lytic action of complement.
Bolande RP; Arnold JL; Mayer DC
Pathol Immunopathol Res; 1989; 8(1):46-60. PubMed ID: 2717531
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a human antibody directed against human neuroblastoma cells and specific for human translation elongation factor 1alpha.
Schilbach K; Kreyenberg H; Geiselhart A; Niethammer D; Handgretinger R
Tissue Antigens; 2004 Feb; 63(2):122-31. PubMed ID: 14705983
[TBL] [Abstract][Full Text] [Related]
5. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen.
Hunt KK; Shibata M; Gupta RK; Morton DL
Cancer Immunol Immunother; 1992; 34(6):377-82. PubMed ID: 1563014
[TBL] [Abstract][Full Text] [Related]
6. Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells.
Ollert MW; David K; Schmitt C; Hauenschild A; Bredehorst R; Erttmann R; Vogel CW
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4498-503. PubMed ID: 8633097
[TBL] [Abstract][Full Text] [Related]
7. Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.
Saarinen UM; Coccia PF; Gerson SL; Pelley R; Cheung NK
Cancer Res; 1985 Nov; 45(11 Pt 2):5969-75. PubMed ID: 2414004
[TBL] [Abstract][Full Text] [Related]
8. Complement-mediated cytolysis and azidothymidine are synergistic in HIV-1 suppression.
Okada H; Wu X; Okada N
Int Immunol; 1998 Jan; 10(1):91-5. PubMed ID: 9488159
[TBL] [Abstract][Full Text] [Related]
9. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
Fukuda M; Nozaki C; Ishiguro Y; Horibe K
Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
[TBL] [Abstract][Full Text] [Related]
10. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
[TBL] [Abstract][Full Text] [Related]
11. A natural immune system in pregnancy serum lethal to human neuroblastoma cells: a possible mechanism of spontaneous regression.
Bolande RP
Perspect Pediatr Pathol; 1992; 16():120-33. PubMed ID: 1470503
[No Abstract] [Full Text] [Related]
12. Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones.
Chen S; Caragine T; Cheung NK; Tomlinson S
Am J Pathol; 2000 Mar; 156(3):1085-91. PubMed ID: 10702424
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM.
Ollert MW; David K; Vollmert C; Juhl H; Erttmann R; Bredehorst R; Vogel CW
Eur J Cancer; 1997 Oct; 33(12):1942-8. PubMed ID: 9516829
[TBL] [Abstract][Full Text] [Related]
14. Presence of IgM antibodies which sensitize HIV-1-infected cells to cytolysis by homologous complement in long-term survivors of HIV infection.
Okada N; Wu X; Okada H
Microbiol Immunol; 1997; 41(4):331-6. PubMed ID: 9159407
[TBL] [Abstract][Full Text] [Related]
15. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
Helfand SC; Hank JA; Gan J; Sondel PM
Cell Immunol; 1996 Jan; 167(1):99-107. PubMed ID: 8548851
[TBL] [Abstract][Full Text] [Related]
16. Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype.
Sawant-Mane S; Estep A; Koski CL
J Neuroimmunol; 1994 Jan; 49(1-2):145-52. PubMed ID: 8294552
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-releasing peptide is a growth factor for human neuroblastomas.
Kim S; Hu W; Kelly DR; Hellmich MR; Evers BM; Chung DH
Ann Surg; 2002 May; 235(5):621-9; discussion 629-30. PubMed ID: 11981207
[TBL] [Abstract][Full Text] [Related]
18. Antibody-complement killing of neuroblastoma cells.
Gee AP; Van Hilten J; Graham-Pole J; Boyle MD
Prog Clin Biol Res; 1985; 175():471-83. PubMed ID: 3991742
[No Abstract] [Full Text] [Related]
19. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies.
Cavanna B; Jiang H; Allaria S; Carpo M; Scarlato G; Nobile-Orazio E
J Neuroimmunol; 2001 Mar; 114(1-2):226-31. PubMed ID: 11240036
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures.
Jauberteau MO; Brindel I; Baumann N; Preud'homme JL
J Neuroimmunol; 1993 Oct; 48(1):53-7. PubMed ID: 8227308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
